Accuracy Coverage Pricing Help Centre Contact
Galapagos NV

Galapagos NV (GLPG) Dividends

Dividend Summary:

There have not been any declared dividends recently.
Euronext Amsterdam
Pharmaceuticals & Biotechnology
  Previous Dividend Next Dividend
Per Share:
Ex-div Date:
Pay Date:
Your Holding: 100 shares 100 shares
Your Payment:

Dividend Payment Calculator

Enter the number of shares you hold:

Calculate Payment

Free dividend email notifications

Declared and Forecast Galapagos NV Dividends

Ex-Div Date Pay Date Type Amount Currency Status
There are no Galapagos NV dividends.

Access our Galapagos NV dividend forecasts and the suite of investor tools free for 30 days.

Try DividendMax free for 30 days

About Galapagos NV

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives.

Galapagos develops therapies with proprietary, novel modes-of-action. Filgotinib, Galapagos' most advanced novel mode-of-action program, was discovered using our proprietary target discovery technology, and is being developed by Gielad in Phase 3 in rheumatoid arthritis, Crohn's disease and ulcerative colitis. Galapagos is progressing multiple programs in inflammation, cystic fibrosis, metabolic diseases, fibrosis, and other disease areas.

Galapagos is listed on Euronext Amsterdam and Brussels and on the NASDAQ; all with the ticker symbol GLPG.


Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0¢
2007 0.0¢ 0%
2008 0.0¢ 0%
2009 0.0¢ 0%
2010 0.0¢ 0%
2011 0.0¢ 0%
2012 0.0¢ 0%
2013 0.0¢ 0%
2014 0.0¢ 0%
2015 0.0¢ 0%
2016 0.0¢ 0%
2017 0.0¢ 0%
2018 0.0¢ 0%
2019 0.0¢ 0%
2020 Login required


Ex-Div Date Pay Date Year Type Frequency Status Amount

Galapagos NV optimized dividend - 12 month history